Dendrite and Hitachi Show Major Increase in Market Share Within Japanese Pharmaceutical Industry.Business Editors MORRISTOWN, N.J.--(BUSINESS WIRE)--Oct. 19, 2000 Hitachi/Dendrite Japanese Market Share has Risen by Over 40% Since Collaboration Announcement in March Dendrite dendrite: see nervous system; synapse. International, Inc., the leading provider of sales and marketing effectiveness Marketing Effectiveness is the function of improving how marketers go to market with the goal of optimizing their marketing spend to achieve even better results for both the short-term and long-term. Also related to Marketing ROI and Return on Marketing Investment (ROMI). solutions for the pharmaceutical industry (NASDAQ/NMS: DRTE DRTE Defence Research Telecommunications Establishment ), announced today that within the third quarter, Hitachi Limited, a major Japanese technology company, expanded their existing Distribution Agreement with Dendrite International to include several more pharmaceutical customers who are to license Dendrite Japan's j-forceWEB solution. The initial partnership was launched in March of this year and since the agreement, Dendrite's market share in the Japanese marketplace has grown by 43%. Dendrite Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , John Bailye commented, "These excellent results with Hitachi, reflect our joint role as Japanese pharma industry leaders. The partnership will continue to strengthen Dendrite's offerings in Japan for a long time." The expanded agreement allows further collaboration in offering "best of breed" solutions to the Japanese Pharmaceutical industry. Hitachi, Ltd. Industrial Information System Group Deputy Director, Osamu Chinone said: "We developed `The Pharmaceutical Solution Showcase', the best solutions showcase for the pharmaceutical industry. Dendrite's new j-forceWEB solution adds another proven solution to our current showcase. We are confident that this product will find a great opportunity in the market and this business collaboration will lead to great things for both companies." About Hitachi, Ltd. Hitachi, Ltd. is one of the world's leading global electronics companies, with fiscal 1998 (ended March 31, 1999) consolidated sales of 7,977 billion yen ($65.9 billion). The company manufactures and markets a wide range of products, including computers, semiconductors, consumer products and power and industrial equipment. Hitachi, Ltd. has 913 subsidiaries, including 276 overseas corporations. Hitachi has been a presence in the U.S. since 1959. There are currently 75 Hitachi companies in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. . Hitachi America, Ltd. is a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Hitachi, Ltd., which markets and manufactures a broad range of electronics, computer systems and products, semiconductors, and provides industrial equipment and services throughout the U.S. Hitachi's Web site: http://www.hitachi.com About Dendrite Dendrite International, Inc. (NASDAQ/NMS:DRTE) designs and supports technology-based knowledge systems that enhance the competitive activities of the sales forces of the world's largest pharmaceutical companies. Over one-third of the pharmaceutical sales representatives pharmaceutical sales representative Detailer, Drug rep Drug industry A drug company employee who regularly visits physicians and office practices, providing information on the company's products–usually putting a negative 'spin' on competitors' products. See Detailing. and their managers in over 57 countries worldwide rely on Dendrite to provide these services to maximize representative effectiveness in the field. Dendrite combines its world-class software products with specifically tailored coaching and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services . Headquartered in Morristown, New Jersey Morristown is a town in Morris County, New Jersey, United States. As of the United States 2000 Census, the town population was 18,544. Its estimated population in 2004 was 18,842. It is the county seat of Morris CountyGR6. , Dendrite employs over 1500 people around the world. For more information, visit the Company's Web site at http://www.dendrite.com. Note: Dendrite is a registered trademark of Dendrite International, Inc. This press release contains statements that are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. and discuss expectations about future events or outcomes with respect to Dendrite and its business, including statements regarding expected results for future periods. We believe these statements are within the scope of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and we intend that these statements be covered by the safe harbors Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. created by such acts. The forward-looking statements are based on our current expectations, assumptions, estimates and projections about our company and the pharmaceutical and consumer packaged goods Noun 1. packaged goods - groceries that are packaged for sale foodstuff, grocery - (usually plural) consumer goods sold by a grocer plural, plural form - the form of a word that is used to denote more than one industries and involve risks and uncertainties. Accordingly, Dendrite's actual results may differ materially from the results discussed in or implied by such forward-looking statements. The risk factors that could cause actual results to differ from the results expressed or implied by these forward-looking statements include the following: (i) our business is heavily dependent on the pharmaceutical industry; (ii) our quarterly results of operations may fluctuate significantly and may not meet market expectations; (iii) our lengthy sales and implementation cycles make it difficult to predict our quarterly revenues; (iv) our fixed costs fixed costs, n.pl the costs that do not change to meet fluctuations in enrollment or in use of services (e.g., salaries, rent, business license fees, and depreciation). may lead to fluctuations in our quarterly operating results if revenues fall below expectations; (v) our business is affected by variations in our customers' budget cycles; (vi) our revenues would decline and our business would be adversely affected by the loss of one of our major customers; (vii) we may be unable to successfully introduce new products or respond to technological change; (viii) timing of revenue recognition is dependent on many factors including timing of customer acceptance of product offerings and execution of contracts for Dendrite products, which factors are often outside the Company's control and which cannot always be predicted (ix) increased competition may result in price reductions and decreased demand for our products and services; (x) some of our customers rely on our competitors for market data; (xi) our international operations Internal Operations (I.O., IO or I/O) is a fictional American Intelligence Agency in Wildstorm comics. It was originally called International Operations. I.O. first appeared in WildC.A.T.S. volume 1 #1 (August, 1992) and was created by Brandon Choi and Jim Lee. have risks that our domestic operations do not; (xii) our success depends on retaining our key senior management team and on attracting and retaining qualified personnel; (xiii) our inability to manage our growth could adversely affect our business; (xiv) our business depends on proprietary technology that we may not be to protect completely; and (xv) the consumer packaged goods industry may have different characteristics from those we are used to in the pharmaceutical industry. In light of the significant uncertainties inherent in these forward-looking statements, you should not consider their inclusion as a representation by us or anyone else that we will achieve our objectives and plans. Moreover, we assume no obligation to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements. For further discussion of these and other factors that could adversely affect Dendrite's financial condition and results of operations consult Dendrite's annual report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and quarterly reports on Form 10-Q Form 10-Q See 10-Q. filed with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion